Carmat (France) Executives
| ALCAR Stock | EUR 0.97 0.03 3.00% |
Carmat employs about 171 people. The company is managed by 6 executives with a total tenure of roughly 45 years, averaging almost 7.0 years of service per executive, having 28.5 employees per reported executive. Discussion of Carmat's management performance can provide insight into the enterprise performance.
| Stephane Piat CEO CEO, Director |
Carmat |
Carmat Management Team Effectiveness
The company has return on total asset (ROA) of (0.3856) % which means that it has lost $0.3856 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5378) %, meaning that it generated substantial loss on money invested by shareholders. Carmat's management efficiency ratios could be used to measure how well Carmat manages its routine affairs as well as how well it operates its assets and liabilities.Carmat Workforce Comparison
Carmat is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 874. Carmat retains roughly 171 in number of employees claiming about 20% of equities under Health Care industry.
Carmat Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Carmat Price Series Summation is a cross summation of Carmat price series and its benchmark/peer.
Carmat Notable Stakeholders
A Carmat stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Carmat often face trade-offs trying to please all of them. Carmat's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Carmat's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Stephane Piat | CEO, Director | Profile | |
| Petrus Jansen | Medical Director | Profile | |
| Francesco Arecchi | Director of Marketing | Profile | |
| Eric Richez | Director of Business Development | Profile | |
| Raouia Bouyanzer | Director of Human Resources | Profile | |
| Pascale dArbonneau | Chief Financial and Administrative Officer | Profile |
About Carmat Management Performance
The success or failure of an entity such as Carmat often depends on how effective the management is. Carmat management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Carmat management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Carmat management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. The company was founded in 2008 and is based in Vlizy-Villacoublay, France. CARMAT operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 81 people.
Carmat Workforce Analysis
Traditionally, organizations such as Carmat use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Carmat within its industry.Carmat Manpower Efficiency
Return on Carmat Manpower
| Revenue Per Employee | 13.7K | |
| Revenue Per Executive | 389.7K | |
| Net Loss Per Employee | 361.8K | |
| Net Loss Per Executive | 10.3M | |
| Working Capital Per Employee | 11.7K | |
| Working Capital Per Executive | 333.3K |
Additional Tools for Carmat Stock Analysis
When running Carmat's price analysis, check to measure Carmat's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmat is operating at the current time. Most of Carmat's value examination focuses on studying past and present price action to predict the probability of Carmat's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmat's price. Additionally, you may evaluate how the addition of Carmat to your portfolios can decrease your overall portfolio volatility.